Alan Mullen to Fatty Liver
This is a "connection" page, showing publications Alan Mullen has written about Fatty Liver.
Connection Strength
1.830
-
Ben Saad A, Arghiani N, Weilheimer AD, Gentile SD, Toles BJ, Tripathi S, Mohsin Sayed S, Chandraker A, Mullen AC. Prime editing models the MTARC1 A165T variant in human liver organoids, demonstrating reduced steatosis, inflammation, and fibrosis. Hepatol Commun. 2026 Oct 01; 10(10).
Score: 0.899
-
Hess A, Gentile SD, Ben Saad A, Rahman RU, Habboub T, Pratt DS, Mullen AC. Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease. EMBO J. 2023 12 11; 42(24):e113898.
Score: 0.738
-
Friedline RH, Noh HL, Suk S, Albusharif M, Dagdeviren S, Saengnipanthkul S, Kim B, Kim AM, Kim LH, Tauer LA, Baez Torres NM, Choi S, Kim BY, Rao SD, Kasina K, Sun C, Toles BJ, Zhou C, Li Z, Benoit VM, Patel PR, Zheng DXT, Inashima K, Beaverson A, Hu X, Tran DA, Muller W, Greiner DL, Mullen AC, Lee KW, Kim JK. IFN?-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease. Nat Commun. 2024 06 29; 15(1):5506.
Score: 0.193